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NonvaricealAbstract Purpose: To identify clinical factors influencing the positive angiographic findings iden-
tifying the bleeding source by angiography and to evaluation of the clinical outcome of emboliza-
tion in angiography positive and in empiric embolization without identifying the bleeding source of
upper gastrointestinal (UGI) bleeding.
Materials and methods: Twenty-one patients were candidates for transcatheter angiography and
embolization and followed up for 3–38 months.
Results: Transcatheter angiography and embolization was technically and clinically successful in
95% and 86% respectively. Angiography identified the source in 11/20 and no source of bleeding
seen in 9/20 in whom empiric embolization was carried out. Technical and clinical success or com-
plications were not different. No procedure related major complications were encountered. Early
and late mortalities were not different. Blood transfusion requirement and rate of hemoglobin drop
were higher in positive compared to empiric group 9 vs 7 U and 5.7 vs 6.5 g/dL respectively
(p= 0.02), (p= 0.1). Coagulopathy was found in 64% (n= 7) in positive and in 38% (n= 3)
in empiric group (p= 0.02). Recurrent UGI bleeding was noticed in patients with coagulopathy
and were treated by coils alone.
Conclusion: Transcatheter angiography and embolization is safe and effective. Embolization can
be done empirically even when angiographically negative is based on endoscopic localization of
bleeding source.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Acute massive upper gastrointestinal (UGI) bleeding in adult
is due to duodenal ulcer in about 30%-40% and gastric ulcer
in 20–25%. In total, a mortality of 5%-15% has been
unchanged during the last three decades often related to
162 M. Abusedera et al.comorbidity (1). Endoscopy is the first line examination and
treatment of UGI bleeding and achieves bleeding control in
up to about 95% of the patients. After primary treatment fail-
ure and recurrence of bleeding, a second endoscopic attempt,
surgery or endovascular embolization should be considered
(2,3). When primary hemostasis has been obtained without
recurrence after endoscopic treatment the mortality is less than
2%. However, in about 15% of cases endoscopy is either not
available or unsuccessful (4).
Re-bleeding after primary control of bleeding is seen in
about 25% of cases and these patients have mortality of about
10%. In about 5% of UGI bleeding it is not possible to stop
the bleeding in the first place and in these cases the mortality
is about 30% (2).
The sensitivity of angiography in detecting the bleeding
source is dependent on the severity of bleeding, and is highest
in hemodynamically instable patients with transfusion require-
ments and a bleeding of at least 1–2 mL/min before recogniz-
ing the bleeding can be expected. Further, the sensitivity is
dependent on the localization of the bleeding, whether the
bleeding is localized or diffused, if it is intermittent, arterial
or venous, the degree of gastric and intestinal content of air,
peristaltics, and patient cooperation. The sensitivity is proba-
bly no more than 50–60% (3,5,6).
Transarterial embolization (TAE) is an effective treatment
with good long term results. Technical success can, in experi-
enced hands, be achieved in 90–98% of cases (4). But about
10% will have rebleeding within 3 days (7). Primary clinical
success with hemostasis in the group of patients with techni-
cally successful embolization is about 80% (4), and secondary
clinical success after reembolization is achieved in more than
80% (8).
In many institutions transcatheter arterial embolization is
considered as the first-line intervention for massive UGI bleed-
ing after failed endoscopic treatment (9,10).
Many authors postulated that when the bleeding source is
not identified which is considered as negative angiography
and this constitutes high percentage of patients, embolization
is not possible (11). Other authors concluded that: high rate
of technical and clinical success was obtained with empiric
transarterial embolization (TAE) comparable to identifiable
TAE in patients with massive bleeding from duodenal ulcers.
There were no severe complications. Empiric TAE is an effec-
tive and safe method when a bleeding site cannot be deter-
mined by angiography (12).
2. Purpose
To identify clinical factors influencing the positive angio-
graphic findings identifying the bleeding source of nonvariceal
upper gastrointestinal bleeding and to evaluation of clinical
and technical outcome for transcatheter embolization of
angiographically positive patient and empiric embolization of
angiographically negative patient in whom angiography could
not identify the bleeding source.
3. Materials and methods
This is retrospective review of all patients (n= 178) who
underwent arterial embolization for acute non variceal UGI
hemorrhage at a university hospital and private practiceHospital between July 2010 to October 2014. Fifteen cases
were excluded because of incomplete medical records. All
patients (n= 163) had an episode of massive acute bleeding
within 7 days of the procedure. Patients who were presented
with fresh hematemesis or circulatory instability underwent
emergency endoscopy procedures by experienced endoscopists.
When massive bleeding was inaccessible or unresponsive to
endoscopic treatment, patients were referred for TAE, which
was the first alternative to endoscopic therapy. CT angiogra-
phy was obtained whenever possible, and it was not performed
in patient who had renal impairment without regular dialysis
and when the patient was hemodynamically unstable.
Technical success was defined as target area devasculariza-
tion and clinical success was defined as clinical cessation of
gastrointestinal bleeding (clearing of nasogastric aspirates
and/or melena) and stabilization of the hemoglobin and hema-
tocrit level, requiring no more than 2 units (U) of packed red
blood cells after the procedure.
If a patient required more than 2 U or hemodynamic insta-
bility persist or persistent hemorrhage that required therapeu-
tic endoscopy, repeat embolization, or surgery after the
primary procedure, the procedure was considered failure.
Clinical data were obtained from the patient’s medical
record including: patient’s age, gender, comorbidity, endo-
scopic diagnosis, blood transfusion requirement before and
after angiography, number of blood units infused, PTT, pro-
thrombin time and INR platelets count., rate of drop of
hematocrit value per in gram per 24 h, rate of hemoglobin
drop g /24 h and serum creatinine level, hospital course, and
in-house mortality either hemorrhage-related mortality or for
other reasons.
Coagulopathy was defined by an international normalized
ratio >1.5, partial thromboplastin time >45 s, or platelet count
less than 80,000 /lL. Thirty days post procedure complication
can be classified as minor or major complications according to
definition by SIR as an unplanned increase in the level of care,
prolonged hospitalization, permanent adverse sequelae, or
death. Median follow-up was 12 months ranged from 3 to
26 months average of 13 months.3.1. Procedure
After obtaining informed consent for the procedure, diagnostic
angiography through common femoral artery access with 5 Fr
sheath was carried out followed by diagnostic celiac and supe-
rior mesenteric angiography. All patients then underwent
selective embolization of at least one vessel, chosen by evidence
of contrast extravasation at angiography which considered
positive angiography or empiric embolization based on endo-
scopic or contrast enhanced CT before angiography. When
angiography was negative, endoscopic findings were used to
target embolization (empiric embolization), and the left gastric
artery was chosen as the target vessel for gastric bleeding and
the gastroduodenal GDA and its branches were chosen for
duodenal bleeding. If subsequent angiogram demonstrated
collateral flow or continued extravasation, a secondary or ter-
tiary embolization was performed. For embolotherapy, Hilal
microcoils platinum 0.18 or Tornado embolization microcoils
Gelfoam pledgets or Gelfoam slurry (Pharmacia & Upjohn,
Kalamazoo, MI) were deployed close to the bleeding site via
superselective catheterization. Sandwich technique used coils
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wiched between coils.
3.2. Analysis
Bleeding recurrence, clinical success, minor complication after
the procedure and early and late mortality and blood transfu-
sion requirement after embolization were compared between
positive group and empiric embolization group using Fisher
exact test for univariate analysis.
4. Result
During 5 years duration, 178 patients were presented with pic-
ture of upper gastrointestinal bleeding with hematemesis and/
or melena. Fifteen patients were excluded because of deficient
medical record in 13 and because of lost follow-up in 2
patients.
One hundred and sixty-three patients had undergone upper
endoscopy. Variceal bleeding either esophageal or gastric was
found in 84 patients. Seventy-nine patients had nonvariceal
upper gastrointestinal hemorrhage, and endoscopy was suc-
cessful to control bleeding in 57 patients but failed in 22
patients. One patient had bleeding and duodenal perforation
required prompted surgical intervention. Twenty-one patients
were the study population (13 M and 8 F). Mean age was
61.2 years ranged from 46 to 83 years. The associated comor-
bidities were renal impairment in 6, ischemic heart disease
and cardiomyopathy in 8, and respiratory failure secondary
to Chronic obstructive airway disease in 4; Liver cirrhosis in
3; and Pancreatic cancer in 1 and gastric cancer in 1. Patients
who have undergone angiography and embolization have been
followed up for period ranged from 3 to 38 months with aver-
age of 17 months and median of 16 months.
The demographic data and associated comorbidity for
patients who had positive angiography (positive group) and
patients who had negative angiography and were treated by
empiric embolization (called empiric group) are shown in
Table 1.Table 1 Demographic and comorbidities of patient in
angiography positive and angiography negative that was






Age 62.6(48–72) 61.3(49–71) 0.6
M 8(72%) 6(66%) 0.3
F 3(27%) 3 (33%)




Respiratory failure 2(18%) 2(22%)
Cancer 1(9%) 1(11%)
DM 5(45%) 4 (44%)
Renal impairment 4(36%) 2 (22%)
DM: Diabetes Mellitus.All of them have undergone TAE after failure of endo-
scopic control (n= 6), or inability to localize the bleeding area
(n= 9) or recurrent bleeding after endoscopic control (n= 6).
Etiology of bleeding was duodenal ulcer (n= 7), gastric
ulcer (n= 6), invasive procedure iatrogenic (n= 2),
Mallory-Weiss tear (n= 3), and hemorrhagic gastritis (n= 3).
CTA was performed in 12 patients, and endoscopy could
not localize exact bleeder in 9 of them and 3 in whom bleeding
recurred after initial control by endoscopy.
CTA was positive with extravasations of contrast in arterial
phase and increased in venus phase 33% (n= 4) (Fig. 1).
Overall technical and clinical success was 95% and 86%
respectively (n= 20 and n= 18). Positive angiography with
active bleeding was seen in 52% (n= 11) and empiric
embolization was done in 43% (n= 9). Technical failure was
encountered in single patient because of celiac trunk stenosis
who was managed surgically. Devascularization of target area
was obtained in 100% in both positive and empiric groups,
and clinical success rates were 91% (n= 10) and 89%
(n= 8) for positive and empiric groups respectively. Recurrent
upper gastrointestinal bleeding was encountered in 2 patients
within 7 days after embolization, one of positive group and
one of empiric group. Only coils were used for embolization
and both of them had coagulopathy with INR was 1.7 and
1.2, prothrombin time was 18 and 15 s and partial thrombo-
plastin time (PTT) was 70 and 50 s respectively. The first recur-
rence has happened, two days after embolization of GDA by
coils alone. Patient was subjected to endoscopy that showed
bleeding could not be controlled endoscopically and sent for
second angiography that has shown recurrent bleeding from
duodenal branch from GDA. The bleeding branch was con-
trolled by coils and PVA. Second patient had bleeding gastric
ulcer that was controlled by empiric embolization of left gas-
tric artery. Three days after embolization slow bleeding from
nasogastric tube was noticed that required three units of blood
transfusion over 24 h. Second endoscopy showed bleeding
from gastric ulcer that was controlled endoscopically (see
Table 2).
Positive angiography group of patients had significantly
higher number of unit of blood transfusion prior to angiogra-
phy. The median number of transfused units for those patients
was 9 U of packed red blood cells (range 5–22 U), that was sig-
nificantly higher than that of empiric embolization group
which was 7 Units (rage 4–16) (P value 0.02).
The mean hemoglobin level for positive group and empiric
group was 5.7 g/dL and 6.5 g g/dL respectively (p= 0.1).
Coagulopathy was found in 64% (n= 7) in positive and in
38% (n= 3) in empiric group (p= 0.02).
Rate of HB drop was higher in positive group than in
empiric group, mean 4 g/day versus 2 g/day, and mean INR
for positive group was 1.8 and that of empiric group was 1.6.
There was no significant difference in comorbidity of both
groups or cause of bleeding.
4.1. Embolized arteries
The patients underwent TAE of the gastroduodenal
artery (GDA), anterior superior pancreaticoduodenal artery
(ASPDA), or posterior superior pancreaticoduodenal artery
(PSPDA), as determined by angiography or endoscopy per-
formed before the procedure. Additional TAE was performed
Fig. 1 (a–e) 75 years old female patient who had cancer head of pancreas and was subjected to ERCP and endoscopically-inserted
biliary stent. Recently patient has presented with profuse upper gastrointestinal bleeding that could not be controlled by upper endoscopy.
Noncontrast CT scan for the abdomen (a) showed the distal end of biliary stent within duodenum (thin arrow), and contrast enhanced CT
(b and c) showed contrast extravasation very close to the distal end of stent (thick arrow). Transcatheter digital subtraction angiography
(DSA) (d) showed contrast extravasation from the duodenal branch of gastroduodenal artery (GDA) that was embolized with tornado
microcoil and PVA particles, and cessation of bleeding was noticed angiographically (e) and clinically after embolization.
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Table 2 Comparison between the outcome of angiography







Recurrent bleeding 1(9%) 1(11%) 0.1








Late mortality 2(18%) 2(22%) 0.2
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pancreatic artery (DPA) if extravasation was shown via the
IPDA or DPA.Fig. 2 (a–c) 81 years old male patient with end stage renal disease on
duodenal ulcer failed endoscopic treatment, and digital subtraction sele
no active extravasation or aneurysm or other angiographic signs of ac
bleeding duodenal ulcer, empiric embolization of GDA with multiple
DSA (c) showed cessation of flow at GDA. Clinically; gastrointestinaWhen the bleeding site was the duodenal bulb, coils were
deployed in the GDA as close to the hepatic artery as possible
to prevent the collateral vessels supplying the duodenal bulb. If
the bleeding site was the postduodenal bulb, coils were
deployed in the ASPDA or PSPDA across the origin of
branches feeding the bleeding site, coils were deployed in
GDA close to hepatic artery in 3 and in whole GDA in 4 bleed-
ing that were postduodenal bulb (empiric) (Fig. 2), left gastric
artery in 6 (empiric in 4 and positive in 2) and in both GDA
and anterior superior duodenal artery in 3 (positive) and pos-
terior superior pancreaticodudenal artery in 2 (positive) and
right gastric artery from the splenic artery in 1 (positive). Jeju-
nal branch from SMA in one positive (Fig. 3) later showed
active bleeding by technetium-tagged RBC scan.
No major procedure-related complications or mortality
related to gastrointestinal bleeding was encountered in either
group. Early 30 days morality was seen in 3 patients, all were
not related to procedure, and all 3 patients had multiorgandialysis presented with severe upper gastrointestinal bleeding from
ctive celiac (a) and SMA (b) angiography which were done revealed
tive bleeding. Based on the upper GI endoscopy finding of active
microcoils and PVA particles was carried out. Postembolization
l bleeding has stopped.
Fig. 3 (a–c) 78 years old male patient suffered from hypertension, respiratory failure, end stage renal disease was presented with
intractable lower gastrointestinal bleeding, upper endoscopy was negative, autologous RBCs labeled with Tc-99m pertechnetate 18mCi
were used for scanning which showed active extravasation at the left upper abdomen mostly at the proximal jejunal loop (a). DSA (b)
showed the jejunal branch from SMA which showed abnormal looking distal branch with abnormal mucosal persistent staining, and super
selective embolization with single microcoil has controlled the bleeding (c). Patient improved clinically without need for further blood
transfusion.
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drome and one patient succumbed to respiratory failure and
one patient suffered from end stag renal disease. Minor com-
plications including nausea and vomiting in 10 cases (7 in pos-
itive and 3 in empiric) and abdominal pain in 7 (3 in positive
and 4 in empiric group) all resolved by conservative treatment
of antiemetic zofran and proton pump inhibitor; H1 blocker
late mortalities were seen in additional 4 patients at 3, 4, 6
and 9 months after embolization first; and two patients died
because of pancreatic cancer and gastric cancer. One patient
deceased because of myocardial infarction and other one
because of respiratory failure complicating chronic obstructive
airway disease.
Postembolization blood transfusion requirement was not
significantly different in both groups ranged from 1 to2 U/24 h in positive group and 1 to 2 U/24 h in empiric group;
median 1 U/24 h for both groups; and mean 1.36/24 h for pos-
itive group and 1.25 U/24 h for empiric group (p= 0.19).5. Discussion
Upper endoscopy is the first line of management of upper GI
Bleeding and it has been successful in 98% of cases (13). When
endoscopy fails to control bleeding, the options are either sur-
gery or transcatheter angiography and embolization. Surgery
is associated with high mortality rate that ranges between
20% and 40% (14).
Transcatheter arterial embolization (TAE) has been
performed for more than 30 years and has been shown to be
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(15–19), with high technical and clinical success rates that
are ranging from 69% to 100% and from 63% to 97% respec-
tively (20). Therefore, currently, transcatheter embolization is
considered as a good alternative to surgery for life-
threatening gastroduodenal bleeding that could not be con-
trolled by endoscopic treatment (8–10,17–19,21). When
endovascular management is planned, obtaining imaging stud-
ies may be helpful. A bleeding site is often difficult to detect by
angiography because massive bleeding is frequently intermit-
tent (22). According to previous reports on endovascular man-
agement of intractable gastroduodenal bleeding, active
extravasation was present in 10–100% of patients at the time
of embolization (19,23,24).
Noninvasive imaging with technetium-99m-labeled red
blood cell (RBC) or Tc-99m sulfur colloid scintigraphy can
be used to detect and localize gastrointestinal bleeding. Tc-
99m RBC scintigraphy is 93% sensitive and 95% specific for
detecting a bleeding site with active arterial or venous bleeding
rates as low as 0.04 mL/min (25).
Bleeding rates as low as 0.5 mL/min can be detected with
selective catheter angiography (26). Angiography has a sensi-
tivity of 63–90% for upper gastrointestinal bleeding, respec-
tively, and a specificity of up to 100% (27,28).
An arteriogram can be obtained following a positive bleed-
ing scan (Fig. 2), as a positive scintigram increases the likeli-
hood of a positive angiogram from 22% to 53% (11). In our
study, angiography showed extravasation in 52% of cases
which is comparable to other authors who detected extravasa-
tion or pseudo aneurysm on angiography in only 39% of 59
patients (12).
In our study, positive angiography patients had criteria of
massive gastrointestinal bleeding that was represented by sig-
nificant higher requirement of blood transfusion and higher
are of HB drop and higher percentage of coagulopathy
although patients with empiric group showed lower require-
ment of blood transfusion and this is consistent with rapid rate
of blood loss. Roughly by simple calculation requirement of
4 units or more of blood transfusion per day means the rate
of blood loss at average of 0.6–1.25 ml/min which would be
detectable by angiography and the lower the rate of blood loss
the higher the possibility to have negative angiography results.
Bleeding, even when massive, is usually intermittent. A
decrease in blood pressure secondary to massive bleeding often
stops the bleeding or slows it down, making it difficult to
detect (29).
Many authors postulated that when angiography is nega-
tive, which constitutes high percentage of patients, emboliza-
tion is not possible (11). Other authors concluded that high
rate of technical and clinical success was obtained with empiric
TAE comparable to identifiable TAE in patients with massive
bleeding from duodenal ulcers. There were no severe complica-
tions. Empiric TAE is an effective and safe method when a
bleeding site cannot be determined by angiography (12).
In this study clinical success of embolization angiography
positive active bleeding was comparable with empiric bleeding
based on the endoscopy diagnosis of the source of bleeding
91% (n= 11) versus 89% (n= 8). In study of Ichiro et al.
(12) the clinical success rate of positive angiography and
empiric embolization of duodenal bleeding diagnosed by upper
endoscopy were 86% (n= 31) and 78% (n= 18) respectivelyand they used Gelfoam as an embolization material but we
used either coils alone or coils with PVA.
The outcome of embolization in positive and empiric
groups was without significant difference as regard the clinical
success and efficacy that was determined by postprocedure
requirement for blood transfusion, and early and late mortal-
ity; none of them was procedure-related and also minor com-
plications were not different in both groups.
The frequency of bleeding recurrence was comparable in
both groups in whom 4 out 5 had coagulopathy and treated
with coils alone and this agreed with the result of Aina et al.
Loffroy et al. reported high rate of bleeding recurrence when
coils only used in patienst with coagulopathy (8,9). This raises
the importance of correction of coagulopathy. There has been
strong correlation among coagulopathy, clinical failure, and
mortality after embolization: patients with coagulopathy are
3 times more likely to experience recurrent bleeding after ini-
tially successful embolization and 10 times more likely to die
as a result of bleeding compared with those with normal coag-
ulation profile (16,8,4). Aina et al. concluded, by multivariate
regression analysis, that the use of coils alone was associated
with recurrent bleeding in cases with coagulopathy, a finding
that supports the use of PVA or Gelfoam in combination with
coils in patients with coagulopathy (8), which agreed with our
successful control of early recurrent bleeding in patients with
coagulopathy by the use of PVA and coils together.
Arterial phase multidetector row helical computed tomog-
raphy (CT) has been reported to be accurate for detection
and localization of bleeding sites in patients with acute massive
GI bleeding. We used CT angiography to help localization of
the source of bleeding and decrease time needed to control the
bleeding (Fig. 1). Some authors do not perform CT routinely
to decrease the contrast dose of the patient and avoid delay
of patient for angiography (12), but on the other hand finding
the source of the bleeding requires multiple superselective
angiography which might be time- consuming and is associated
with utilization of excessive contrast. In this study CTA was
positive only in 33% of cases and this can be explained by
the very short period of image acquisition in CTA and the
course of bleeding that might be intermittent. Severe bleeding
generates selective mesenteric hypoperfusion by producing a
disproportionate mesenteric vasospasm that is mediated pri-
marily by the renin-angiotensin axis (30).
Our study was not randomized controlled study and it had
small number of patients with empiric and positive angiogra-
phy. We used either coils alone or combination of coils and
PVA.
This study showed that the more severe the blood loss the
more likely to have positive angiography. Even when angiog-
raphy was negative empiric embolization could be done safely
with high clinical outcome based on endoscopy localization of
upper gastrointestinal hemorrhage. The use of coils alone in
patient with coagulopathy was associated with early recurrence
and PVA should be used with coils. Transcatheter
embolization of upper gastrointestinal bleeding was safe and
effective.Conflict of interest
We have no conflict of interest to declare.
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